{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:50:13Z","timestamp":1757454613205},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1378\/chest.120.3.796","type":"journal-article","created":{"date-parts":[[2003,6,13]],"date-time":"2003-06-13T20:09:19Z","timestamp":1055534959000},"page":"796-800","source":"Crossref","is-referenced-by-count":20,"title":["Primary Pulmonary Hypertension Is Not Associated With Scleroderma-Like Changes in Nailfold Capillaries"],"prefix":"10.1016","volume":"120","author":[{"given":"Eric L.","family":"Greidinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean P.","family":"Gaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christy","family":"Boling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Traci","family":"Housten-Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrick M.","family":"Wigley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.120.3.796_bib1","doi-asserted-by":"crossref","first-page":"51A","DOI":"10.1016\/S0002-9149(99)80383-X","article-title":"Pathology and pathophysiology of primary pulmonary hypertension","volume":"75","author":"Rubin","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.120.3.796_bib2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jmg.37.10.741","article-title":"Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family","volume":"37","author":"Thompson","year":"2000","journal-title":"J Med Genet"},{"key":"10.1378\/chest.120.3.796_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9343(83)91169-5","article-title":"Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis","volume":"75","author":"Ungerer","year":"1983","journal-title":"Am J Med"},{"key":"10.1378\/chest.120.3.796_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/ard.57.11.682","article-title":"Mortality and causes of death in a Swedish series of systemic sclerosis patients","volume":"57","author":"Hesselstrand","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.120.3.796_bib5","first-page":"389","article-title":"Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension","volume":"146","author":"Chadzova","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1378\/chest.120.3.796_bib6","first-page":"1038","article-title":"Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study","volume":"16","author":"al-Sabbagh","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.120.3.796_bib7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension: a national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.120.3.796_bib8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: the Primary Pulmonary Hypertension Study Group","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.120.3.796_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"issue":"suppl","key":"10.1378\/chest.120.3.796_bib10","doi-asserted-by":"crossref","first-page":"231S","DOI":"10.1378\/chest.114.3_Supplement.231S","article-title":"Genetics and immunogenetic aspects of primary pulmonary hypertension","volume":"114","author":"Barst","year":"1998","journal-title":"Chest"},{"key":"10.1378\/chest.120.3.796_bib11","first-page":"4","article-title":"Nailfold capillary abnormalities","volume":"8","author":"Maricq","year":"1982","journal-title":"Clin Rheum Dis"},{"key":"10.1378\/chest.120.3.796_bib12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/art.1780240704","article-title":"Blind evaluation of the diagnostic specificity of nailfold capillary microscopy in the connective tissue diseases","volume":"24","author":"Kenik","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.120.3.796_bib13","first-page":"2226","article-title":"The evolution of Raynaud's phenomenon: a long-term prospective study","volume":"22","author":"Luggen","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.120.3.796_bib14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1378\/chest.117.3.870","article-title":"Anorexigens and pulmonary hypertension in the United States: results from the Surveillance of North American Pulmonary Hypertension","volume":"117","author":"Rich","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.120.3.796_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma): Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostics and Therapeutics Criteria Committee","volume":"23","author":"American Rheumatism Association","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.120.3.796_bib16","first-page":"879","article-title":"Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison","volume":"24","author":"Maricq","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.120.3.796_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0197-2456(98)00046-4","article-title":"Behavioral and pharmacologic interventions: the Raynaud's Treatment Study","volume":"20","author":"Thompson","year":"1999","journal-title":"Control Clin Trials"},{"key":"10.1378\/chest.120.3.796_bib18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/art.1780240907","article-title":"Widefield capillary microscopy","volume":"24","author":"Maricq","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.120.3.796_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1378\/chest.120.3.796_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/ard.55.8.507","article-title":"Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls","volume":"55","author":"Kabasakal","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.120.3.796_bib21","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/art.1780301014","article-title":"In vivo capillary microscopy findings and ophthalmoscopy findings in scleroderma","volume":"30","author":"Ranft","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.120.3.796_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199801293380501","article-title":"Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacylin) therapy in primary pulmonary hypertension","volume":"338","author":"McLaughlin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.120.3.796_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(83)91624-0","article-title":"Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome: a double-blind controlled trial","volume":"1","author":"Belch","year":"1983","journal-title":"Lancet"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215501591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215501591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T15:59:40Z","timestamp":1553097580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215501591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S0012369215501591"],"URL":"https:\/\/doi.org\/10.1378\/chest.120.3.796","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}